Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications

Advances in our understanding of the mechanisms driving castration-resistant prostate cancer have promoted the development of several new drugs including androgen receptor-directed therapy and chemotherapy. Concomitant docetaxel treatment at the beginning of hormonal therapy for metastatic prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Naoki, Akamatsu, Shusuke, Kobayashi, Takashi, Inoue, Takahiro, Ogawa, Osamu, Antonarakis, Emmanuel S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524249/
https://www.ncbi.nlm.nih.gov/pubmed/28794807
http://dx.doi.org/10.1177/1758834017719215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524249/
https://www.ncbi.nlm.nih.gov/pubmed/28794807
http://dx.doi.org/10.1177/1758834017719215

Ejemplares similares